Literature DB >> 31690025

Correction: Fast Tac Metabolizers at Risk-It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587.

Katharina Schütte-Nütgen1, Gerold Thölking2, Julia Steinke3, Hermann Pavenstädt4, René Schmidt5, Barbara Suwelack6, Stefan Reuter7.   

Abstract

The authors wish to make the following corrections to this paper [...].

Year:  2019        PMID： 31690025      PMCID： PMC6912213          DOI： 10.3390/jcm8111870

Source DB:  PubMed          Journal:  J Clin Med        ISSN： 2077-0383            Impact factor:   4.241


The authors wish to make the following corrections to this paper [1]. The authors made an error regarding the rejection-free survival curve in Figure 4A. Figure 4 needs to be corrected. should be replaced with The authors apologize to the readers for any inconvenience caused by these changes. It is important to state that this correction do not affect our study’s results and involve no changes or modifications in the original data supporting our results. The original manuscript will remain online on the article webpage, with reference to this Correction.
  1 in total

1.  Fast Tac Metabolizers at Risk ⁻ It is Time for a C/D Ratio Calculation.

Authors:  Katharina Schütte-Nütgen; Gerold Thölking; Julia Steinke; Hermann Pavenstädt; René Schmidt; Barbara Suwelack; Stefan Reuter
Journal:  J Clin Med       Date:  2019-04-28       Impact factor: 4.241
  1 in total
  9 in total

1.  Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Authors:  Jing Zhu; Tejendra Patel; Jordan A Miller; Chad D Torrice; Mehak Aggarwal; Margaret R Sketch; Maurice D Alexander; Paul M Armistead; James M Coghill; Tatjana Grgic; Katarzyna J Jamieson; Jonathan R Ptachcinski; Marcie L Riches; Jonathan S Serody; John L Schmitz; J Ryan Shaw; Thomas C Shea; Oscar Suzuki; Benjamin G Vincent; William A Wood; Kamakshi V Rao; Tim Wiltshire; Eric T Weimer; Daniel J Crona
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

2.  Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial.

Authors:  Barbara Suwelack; Suphamai Bunnapradist; Ulf Meier-Kriesche; Daniel R Stevens; Claudio Procaccianti; Roberto Morganti; Klemens Budde
Journal:  Ann Transplant       Date:  2020-07-28       Impact factor: 1.530

3.  The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial.

Authors:  Ulrich Jehn; Anja Kortenhorn; Katharina Schütte-Nütgen; Gerold Thölking; Florian Westphal; Markus Strauss; Dirk-Oliver Wennmann; Hermann Pavenstädt; Barbara Suwelack; Dennis Görlich; Stefan Reuter
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

4.  Improved Kidney Allograft Function after Early Conversion of Fast IR-Tac Metabolizers to LCP-Tac.

Authors:  Gerold Thölking; Filiz Tosun-Koç; Ulrich Jehn; Raphael Koch; Hermann Pavenstädt; Barbara Suwelack; Stefan Reuter
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

5.  The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial.

Authors:  Teerada Susomboon; Yotsaya Kunlamas; Somratai Vadcharavivad; Attapong Vongwiwatana
Journal:  Sci Rep       Date:  2022-08-21       Impact factor: 4.996

6.  Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.

Authors:  Klemens Budde; Lionel Rostaing; Umberto Maggiore; Giovanni Piotti; Daniela Surace; Silvia Geraci; Claudio Procaccianti; Gabriele Nicolini; Oliver Witzke; Nassim Kamar; Laetitia Albano; Matthias Büchler; Julio Pascual; Alex Gutiérrez-Dalmau; Dirk Kuypers; Thomas Wekerle; Maciej Głyda; Mario Carmellini; Giuseppe Tisone; Karsten Midtvedt; Lars Wennberg; Josep M Grinyó
Journal:  Transpl Int       Date:  2022-03-21       Impact factor: 3.842

7.  Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation.

Authors:  Ulrich Jehn; Nathalie Wiedmer; Göran Ramin Boeckel; Hermann Pavenstädt; Gerold Thölking; Stefan Reuter
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

8.  Role of Tacrolimus C/D Ratio in the First Year After Pediatric Liver Transplantation.

Authors:  Benas Prusinskas; Sinja Ohlsson; Simone Kathemann; Denisa Pilic; Kristina Kampmann; Rainer Büscher; Andreas Paul; Lars Pape; Peter F Hoyer; Elke Lainka
Journal:  Front Pediatr       Date:  2021-06-02       Impact factor: 3.418

9.  Recent Advances and Clinical Outcomes of Kidney Transplantation.

Authors:  Charat Thongprayoon; Panupong Hansrivijit; Napat Leeaphorn; Prakrati Acharya; Aldo Torres-Ortiz; Wisit Kaewput; Karthik Kovvuru; Swetha R Kanduri; Tarun Bathini; Wisit Cheungpasitporn
Journal:  J Clin Med       Date:  2020-04-22       Impact factor: 4.964
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.